CPAQ-8-BC
Completed
101 enrolled
Harvesting Cells for Experimental Cancer Treatments
Enrolling by invitation
7,000 enrolled
RESOLBE
Recruiting
60 enrolled
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Recruiting
1,100 enrolled
MOMENTUM
Recruiting
8,000 enrolled
QVA-Mod
Not yet recruiting
180 enrolled
Effectiveness, Safety, and Tolerability of Anti-HER2 Drugs as Targeted Therapy for Egyptian Patients With ERBB2-Positive Breast Cancer
Completed
80 enrolled
MAGNETO
Recruiting
772 enrolled
BASECAMP-1
Recruiting
200 enrolled
EXERT-BCHC
Recruiting
15 enrolled
EXoPERT EMERALD Clinical Study
Recruiting
1,400 enrolled
CHARM1
Active not recruiting
1,416 enrolled
A Prospective Study to Develop and Clinically Validate an in Vitro Diagnostic Medical Device That Uses Blood to Classify Patients at High Risk for Breast Cancer
Recruiting
330 enrolled
ELEPHAS-05
Recruiting
2,000 enrolled
Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
Completed
40 enrolled
IMPLICATION
Completed
167 enrolled
PDM-MBC
Active not recruiting
97 enrolled
UNC Pleural Fluid Registry
Recruiting
9,999 enrolled
YASU Research Registry: For Young Adults With Cancer
Terminated
192 enrolled
MITOX
Not yet recruiting
500 enrolled
ML-CardioTox
Not yet recruiting
600 enrolled
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
Recruiting
350 enrolled
The Effect of Aerobic Exercise on Selective Biomarkers of Patients With Cancer
Completed
32 enrolled
Characterizing Fatigue Experienced by Cancer Patients Receiving Primary Treatment and Cancer Survivors
Terminated
163 enrolled
Assessment of Paclitaxel-Induced Neuropathy
Active not recruiting
43 enrolled
AIM-RÖ
Completed
60,000 enrolled
Study of Radiation Exposure and Bilateral Breast Cancer
Active not recruiting
1,699 enrolled
Early Ageing During Therapy in AYA Cancer Patients
Recruiting
120 enrolled
Tempus Priority Study: A Pan-tumor Observational Study
Active not recruiting
1,000 enrolled
SURVIMON
Active not recruiting
100,000 enrolled
Integrin αvβ6-targeted PET in Malignant Tumors
Recruiting
200 enrolled
Eligibility Screening for the NIH Intramural Research Program Clinical Protocols
Completed
19,522 enrolled
CUPIDON
Completed
106 enrolled
SAHARA-01
Recruiting
500 enrolled
SOMEST'ALIM2
Not yet recruiting
96 enrolled
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
Recruiting
15,000 enrolled
Effect of Genetic Polymorphism on Capecitabine-Induced Toxicity in Egyptian Cancer Patients
Recruiting
80 enrolled
Survivorship
Recruiting
45 enrolled
QUANTUM
Enrolling by invitation
3,000 enrolled
Study of the P16 Gene as a Predictor of Myelosuppression in Breast Cancer Patients
Completed
100 enrolled
SIMBA
Completed
36,444 enrolled 2 charts
CHRONO
Completed
124 enrolled
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
Completed
484 enrolled
Oncoliq: Early Breast Cancer Detection Based on Liquid Biopsies and microRNAs
Recruiting
364 enrolled
A Retrospective Real-world Study of Abemaciclib in HR+ Breast Cancer
Not yet recruiting
200 enrolled
CER
Recruiting
15,000 enrolled
ARGONAUT: Stool and Blood Sample Bank for Cancer Patients
Recruiting
5,000 enrolled
Multimodal Assesment of Acute Cardiac Toxicity Induced by Thoracic Radiotherapy in Cancer Patients
Completed
47 enrolled
ASAP
Recruiting
25,000 enrolled
The Suitability of Sniff Dog as a Tool in Screening Tumors
Recruiting
4,000 enrolled